[1] 靳延举,党小珂,熊桂林.钼靶X线摄影联合MRI增强扫描检查在DCIS诊断中的应用[J].现代诊断与治疗,2021,32(1):103-105. [2] SHIN H J, CHOI W J, PARK S Y, et al.Prediction of Underestimation Using Contrast-Enhanced Spectral Mammography in Patients Diagnosed as Ductal Carcinoma In Situ on Preoperative Core Biopsy[J]. Clinical breast cancer,2022,22(3):374-386. [3] SHOJAKU H,HORI R,YOSHIDA T, et al.Low-grade ductal carcinoma in situ (DCIS) arising in a fibroadenoma of the breast during 5 years follow-up: A case report[J]. Medicine,2021,100(10):2402-2405. [4] 汤程旭,陈文龙,杨蕊.MRI增强扫描联合钼靶X线在DCIS的诊断价值[J].中华普外科手术学杂志(电子版),2020,14(5):480-482. [5] 孙强,徐兵河,邵志敏.乳腺原位癌诊疗专家共识[J].中华肿瘤杂志,2016, 38(12):942-947. [6] 郭芳. MRI增强扫描联合乳腺钼靶成像在DCIS诊断中的应用研究[J].基层医学论坛,2020,24(19):2762-2763. [7] CHEN W X, SHEN J, LIU X.Comparison of the Diagnostic Value of Mammographyand Ultrasonography for Breast Ductal Carcinomain situ[J]. Indian Journal of Pharmaceutical Sciences,2020,11(3):279-281. [8] 姜红军,李杰,欧胜胜,等.超声、钼靶X线联合MRI增强扫描检查在DCIS诊断中的临床价值探究[J].影像研究与医学应用,2018,2(15):54-55. [9] 杨晓云,崔兰柱,贾玉荣,等.钼靶及MRI增强扫描动态增强及扩散加权序列对DCIS及浸润癌诊断的对比研究[J].空军医学杂志,2018,34(3):202-205. [10] PRABHAKAR A, WANI D I, SHARMA S, et al.Profile of Digital Mammography Findings in Patients with Histopathologically Proven Ductal Carcinoma in Situ (DCIS)[J]. Galician Medical Journal,2020,27(1):1147-1152. [11] 郭胜春. 全数字化乳腺钼靶单独与联合磁共振诊断DCIS的准确度和成本效益分析[J].现代肿瘤医学,2021,29(1):120-123. [12] 王春光,郝宗爱,闫少华,等.MRI增强扫描与乳腺钼靶成像在鉴别DCIS中应用研究[J].中国CT和MRI杂志,2018,16(1):91-93. [13] 葛继元,钱超颖,罗一烽.钼靶X线摄影联合增强磁共振成像在DCIS诊断中的价值[J].实用临床医药杂志,2020,24(8):18-22. [14] 王杏娟,孙淑芹,王靖红,等.DCIS的钼靶及磁共振表现及联合诊断价值[J].中国CT和MRI杂志,2021,19(10):95-97. |